Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
María S. García‐Gutiérrez, Francisco Navarrete, Ani Gasparyan, et al.
Biomolecules (2020) Vol. 10, Iss. 11, pp. 1575-1575
Open Access | Times Cited: 210

Showing 1-25 of 210 citing articles:

Citrus limon L. (lemon) seed extract shows neuro-modulatory activity in an in vivo thiopental-sodium sleep model by reducing the sleep onset and enhancing the sleep duration
Md. Mominur Rahman, Fahadul Islam, Anwar Parvez, et al.
Journal of Integrative Neuroscience (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 68
Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential
Minlan Yuan, Biao Yang, Gerson Rothschild, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 68
An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects
Nadia Martínez Naya, Jazmin Kelly, Giuliana Corna, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 473-473
Open Access | Times Cited: 21
Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain
Barbara Stella, Francesca Baratta, Carlo Della Pepa, et al.
Drugs (2021) Vol. 81, Iss. 13, pp. 1513-1557
Open Access | Times Cited: 98
Promising Nanocarriers to Enhance Solubility and Bioavailability of Cannabidiol for a Plethora of Therapeutic Opportunities
Lucia Grifoni, Giulia Vanti, Rosa Donato, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 6070-6070
Open Access | Times Cited: 67
Neuropharmacological and Antidiabetic Potential of Lannea coromandelica (Houtt.) Merr. Leaves Extract: An Experimental Analysis
Fahadul Islam, Saikat Mitra, Mohamed H. Nafady, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 58
Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions
Ana Tadijan, Ignacija Vlašić, Josipa Vlainić, et al.
Antioxidants (2022) Vol. 11, Iss. 10, pp. 2049-2049
Open Access | Times Cited: 38
The therapeutic potential of purified cannabidiol
Saoirse E. O’Sullivan, Sanne Jensen, Gitte Nykjaer Nikolajsen, et al.
Journal of Cannabis Research (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 29
Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration
Grace Tsz Yan Yau, Waiting Tai, Jonathon C. Arnold, et al.
Pharmaceutical Research (2023) Vol. 40, Iss. 5, pp. 1087-1114
Open Access | Times Cited: 26
An overview on synthetic and biological activities of cannabidiol (CBD) and its derivatives
Xiuli Wang, Huanbang Zhang, Yan Liu, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106810-106810
Closed Access | Times Cited: 26
Latest updates on the serotonergic system in depression and anxiety
Jianwen Lin, Wenxin Liu, Jing Guan, et al.
Frontiers in Synaptic Neuroscience (2023) Vol. 15
Open Access | Times Cited: 24
Development of cannabidiol derivatives as potent broad-spectrum antibacterial agents with membrane-disruptive mechanism
Shanfang Fang, Wen-Tyng Kang, Haizhou Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 266, pp. 116149-116149
Closed Access | Times Cited: 9
Novel rapid treatment options for adolescent depression
Sandra Ledesma‐Corvi, Jordi Jornet-Plaza, Laura Gálvez‐Melero, et al.
Pharmacological Research (2024) Vol. 201, pp. 107085-107085
Open Access | Times Cited: 9
Cannabidiol Intervention for Muscular Tension, Pain, and Sleep Bruxism Intensity—A Randomized, Double-Blind Clinical Trial
Karolina Walczyńska-Dragon, Anna Kurek-Górecka, Wojciech Niemczyk, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 5, pp. 1417-1417
Open Access | Times Cited: 8
Cannabidiol and Neurodegeneration: From Molecular Mechanisms to Clinical Benefits
Saurabh Kumar Jha, Vinod K. Nelson, Punna Rao Suryadevara, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102386-102386
Closed Access | Times Cited: 8
Schizophrenia detection using distributed activation function-based statistical attentional bidirectional-long short-term memory
Safa Amer Ali, Suraiya Parveen, Ihtiram Raza Khan, et al.
Computers in Biology and Medicine (2025) Vol. 186, pp. 109650-109650
Closed Access | Times Cited: 1
Exploring the Anxiolytic, Antidepressant, and Immunomodulatory Effects of Cannabidiol in Acute Stress Rat Models
H. Zlatanova, Maria Georgieva-Kotetarova, N. Vilmosh, et al.
Applied Biosciences (2025) Vol. 4, Iss. 1, pp. 4-4
Open Access | Times Cited: 1
Cannabidiol - a friend or a foe?
Bianca-Maria Tihăuan, Tatiana Onisei, Walter Slootweg, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107036-107036
Open Access | Times Cited: 1
Delivering therapeutic cannabinoids via skin: Current state and future perspectives
Akeemat O. Tijani, Divya Thakur, Dhruv Mishra, et al.
Journal of Controlled Release (2021) Vol. 334, pp. 427-451
Closed Access | Times Cited: 51
Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment
Raquel Maria Pereira Campos, Andrey F. L. Aguiar, Yolanda Paes-Colli, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 43
Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression
Ferenc Zádor, Sâmia R.L. Joca, Gábor Nagy-Grócz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5903-5903
Open Access | Times Cited: 41
Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
Amaya Austrich-Olivares, María S. García‐Gutiérrez, Lucía Illescas, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 473-473
Open Access | Times Cited: 32
Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry
Raphael Rifkin‐Zybutz, Simon Erridge, Carl Holvey, et al.
Psychopharmacology (2023) Vol. 240, Iss. 8, pp. 1735-1745
Open Access | Times Cited: 19
Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review
Kuldeep Singh, Bharat Bhushan, Dilip Kumar Chanchal, et al.
Behavioural Neurology (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 18
Acute and Extended Anxiolytic Effects of Cannabidiol in Cannabis Flower: A Quasi-Experimental ad libitum Use Study
L. Cinnamon Bidwell, Renée Martin‐Willett, Carillon J. Skrzynski, et al.
Cannabis and Cannabinoid Research (2024) Vol. 9, Iss. 4, pp. 1015-1027
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top